A Comprehensive Appraisal of Risk Prediction Models for Cardiogenic Shock.
暂无分享,去创建一个
D. Holmes | A. Truesdell | W. Nicholson | S. van Diepen | J. Katz | N. Kapur | S. Vallabhajosyula | W. Jaber | A. Bhat | Ashequl M Islam | Venugopal Menon | Benham N Tehrani | David X. Zhao | Wissam A Jaber | Sean van Diepen | David X Zhao
[1] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.
[2] F. Pappalardo,et al. Validation of Prognostic Scores in Extracorporeal Life Support: A Multi-Centric Retrospective Study , 2021, Membranes.
[3] M. Bell,et al. Defining Shock and Preshock for Mortality Risk Stratification in Cardiac Intensive Care Unit Patients. , 2021, Circulation. Heart failure.
[4] V. Rao,et al. Predicting Survival After VA-ECMO for Refractory Cardiogenic Shock: Validating the SAVE Score , 2020, CJC open.
[5] D. Burkhoff,et al. Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality. , 2020, JACC. Heart failure.
[6] M. Bell,et al. Shock in the cardiac intensive care unit: Changes in epidemiology and prognosis over time. , 2020, American heart journal.
[7] B. Gersh,et al. Sex Disparities in the Management and Outcomes of Cardiogenic Shock Complicating Acute Myocardial Infarction in the Young , 2020, Circulation. Heart failure.
[8] B. Gersh,et al. Sex and Gender Disparities in the Management and Outcomes of Acute Myocardial Infarction-Cardiogenic Shock in Older Adults. , 2020, Mayo Clinic proceedings.
[9] N. Desai,et al. Transition to Advanced Therapies Among Elderly Patients Supported by Extracorporeal Membrane Oxygenation Therapy: Chouairi et al, ECMO in the Elderly. , 2020, Journal of cardiac failure.
[10] N. Shah,et al. Cardiogenic shock and cardiac arrest complicating ST-segment elevation myocardial infarction in the United States, 2000-2017. , 2020, Resuscitation.
[11] N. Shah,et al. Long-Term Outcomes of Acute Myocardial Infarction With Concomitant Cardiogenic Shock and Cardiac Arrest. , 2020, The American journal of cardiology.
[12] Wei-Ren Lan,et al. Application and Comparison of Different Prognostic Scoring Systems in Patients Who Underwent Cardiologist-Managed Percutaneous Cardiopulmonary Support. , 2020, Acta Cardiologica Sinica.
[13] B. Gersh,et al. Epidemiological Trends in the Timing of In-Hospital Death in Acute Myocardial Infarction-Cardiogenic Shock in the United States , 2020, Journal of clinical medicine.
[14] D. Burkhoff,et al. Value of Hemodynamic Monitoring in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support. , 2020, Circulation.
[15] P. Noseworthy,et al. Burden of Arrhythmias in Acute Myocardial Infarction Complicated by Cardiogenic Shock. , 2020, The American journal of cardiology.
[16] A. Jaffe,et al. Complications in Patients with Acute Myocardial Infarction Supported with Extracorporeal Membrane Oxygenation , 2020, Journal of clinical medicine.
[17] B. Gersh,et al. Regional Variation in the Management and Outcomes of Acute Myocardial Infarction With Cardiogenic Shock in the United States , 2020, Circulation. Heart failure.
[18] H. Thiele,et al. External validation and comparison of the CardShock and IABP-SHOCK II risk scores in real-world cardiogenic shock patients. , 2020, European heart journal. Acute cardiovascular care.
[19] G. Lemesle,et al. Etiology and Prognosis of Cardiogenic Shock in a Secondary Center without Surgical Back-Up , 2019, Cardiology research and practice.
[20] B. Gersh,et al. Extracorporeal Membrane Oxygenation Use in Acute Myocardial Infarction in the United States, 2000 to 2014. , 2019, Circulation. Heart failure.
[21] B. Gersh,et al. Acute respiratory failure and mechanical ventilation in cardiogenic shock complicating acute myocardial infarction in the USA, 2000–2014 , 2019, Annals of Intensive Care.
[22] E. Ohman,et al. Management of cardiogenic shock complicating myocardial infarction: an update 2019. , 2019, European heart journal.
[23] D. Holmes,et al. Hospital-Level Disparities in the Outcomes of Acute Myocardial Infarction With Cardiogenic Shock. , 2019, The American journal of cardiology.
[24] Dennis H. Murphree,et al. Utilization of Palliative Care for Cardiogenic Shock Complicating Acute Myocardial Infarction: A 15‐Year National Perspective on Trends, Disparities, Predictors, and Outcomes , 2019, Journal of the American Heart Association.
[25] B. Gersh,et al. Sex disparities in acute kidney injury complicating acute myocardial infarction with cardiogenic shock , 2019, ESC heart failure.
[26] J. Ornato,et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[27] Dennis H. Murphree,et al. Cardiogenic Shock in Takotsubo Cardiomyopathy Versus Acute Myocardial Infarction: An 8-Year National Perspective on Clinical Characteristics, Management, and Outcomes. , 2019, JACC. Heart failure.
[28] L. Stevenson,et al. Trends in Utilization and Outcomes of Pulmonary Artery Catheterization in Heart Failure With and Without Cardiogenic Shock. , 2019, Journal of cardiac failure.
[29] C. O'connor,et al. Standardized Team-Based Care for Cardiogenic Shock. , 2019, Journal of the American College of Cardiology.
[30] D. Morrow,et al. Epidemiology of Shock in Contemporary Cardiac Intensive Care Units: Data From the Critical Care Cardiology Trials Network Registry , 2019, Circulation. Cardiovascular quality and outcomes.
[31] R. Yeh,et al. Extracorporeal Membrane Oxygenation Use in Cardiogenic Shock: Impact of Age on In-Hospital Mortality, Length of Stay, and Costs , 2019, Critical care medicine.
[32] Dennis H. Murphree,et al. Development and performance of a novel vasopressor-driven mortality prediction model in septic shock , 2018, Annals of Intensive Care.
[33] Biao Xu,et al. The value of shock index in prediction of cardiogenic shock developed during primary percutaneous coronary intervention , 2018, BMC Cardiovascular Disorders.
[34] C. Berry,et al. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS. , 2018, Journal of the American College of Cardiology.
[35] A. Mebazaa,et al. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction. , 2018, Journal of the American College of Cardiology.
[36] D. Boulmier,et al. Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score , 2018, European heart journal.
[37] C. Hassager,et al. Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients , 2018, European heart journal. Acute cardiovascular care.
[38] K. Alaswad,et al. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[39] H. Thiele,et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock , 2017, The New England journal of medicine.
[40] E. Ohman,et al. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association , 2017, Circulation.
[41] K. Anstrom,et al. Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial. , 2017, Journal of the American College of Cardiology.
[42] H. Thiele,et al. Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction. , 2017, Journal of the American College of Cardiology.
[43] E. Ohman,et al. Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock. , 2017, The American journal of cardiology.
[44] S. Shin,et al. Validation of the Shock Index, Modified Shock Index, and Age Shock Index for Predicting Mortality of Geriatric Trauma Patients in Emergency Departments , 2016, Journal of Korean medical science.
[45] S. Champion. Toward Catecholamine Responsiveness in Cardiogenic Shock: Insights from the CRASH Score , 2016, The International journal of artificial organs.
[46] G. Schuler,et al. Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial. , 2016, American heart journal.
[47] P. Leprince,et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock , 2016, Intensive Care Medicine.
[48] S. Chaparro,et al. Incidence of Hemolysis in Patients with Cardiogenic Shock Treated with Impella Percutaneous Left Ventricular Assist Device , 2014, ASAIO journal.
[49] Volkmar Falk,et al. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.
[50] Michael Bailey,et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. , 2015, European heart journal.
[51] E. Ohman,et al. Management of cardiogenic shock. , 2015, European heart journal.
[52] Holger Thiele,et al. Clinical picture and risk prediction of short‐term mortality in cardiogenic shock , 2015, European journal of heart failure.
[53] D. Yellon,et al. Myocardial reperfusion injury: looking beyond primary PCI. , 2013, European heart journal.
[54] James O. Mudd,et al. The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[55] Huadong Zhu,et al. Modified shock index and mortality rate of emergency patients. , 2012, World journal of emergency medicine.
[56] Jorge Yarzebski,et al. Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions. , 2010, The American journal of medicine.
[57] H. White,et al. A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry. , 2010, American heart journal.
[58] J. Vincent,et al. Comparison of dopamine and norepinephrine in the treatment of shock. , 2010, The New England journal of medicine.
[59] M. Mack,et al. Assessment of the SYNTAX score in the Syntax study. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[60] G. De Luca,et al. Cardiogenic shock developing in the coronary care unit in patients with ST-elevation myocardial infarction , 2008, Journal of cardiovascular medicine.
[61] Therapy Study Investigators,et al. A comparison of epinephrine and norepinephrine in critically ill patients , 2008, Intensive Care Medicine.
[62] M. Hamon,et al. Prognostic impact of right ventricular involvement in patients with acute myocardial infarction: Meta-analysis , 2008, Critical care medicine.
[63] T. Fabian,et al. New vitals after injury: shock index for the young and age x shock index for the old. , 2008, The Journal of surgical research.
[64] D. Yellon,et al. Myocardial reperfusion injury. , 2007, The New England journal of medicine.
[65] Min Zhang,et al. A risk‐predictive score for cardiogenic shock after acute myocardial infarction in Chinese patients , 2007, Clinical cardiology.
[66] N. Chi,et al. Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue* , 2006, Critical care medicine.
[67] L. Klein,et al. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. , 2005, The American journal of cardiology.
[68] T. LeJemtel,et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. , 2004, Journal of the American College of Cardiology.
[69] H. White,et al. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. , 2003, Journal of the American College of Cardiology.
[70] H. White,et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.
[71] R. Califf,et al. Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. , 1999, American heart journal.
[72] J. Gurwitz,et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. , 1999, The New England journal of medicine.
[73] E R Bates,et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, Journal of the American College of Cardiology.
[74] Frans Van de Werf,et al. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.
[75] M. Gheorghiade,et al. Risk identification at the time of admission to coronary care unit in patients with suspected myocardial infarction. , 1988, American heart journal.